Handle With Care: Syros Pharmaceuticals Inc (NASDAQ: SYRS)
Currently, there are 26.45M common shares owned by the public and among those 19.70M shares have been available to trade. The company’s stock has a 5-day price change of 7.91% and 69.04% over the past three months. SYRS shares are trading -64.96% year to date (YTD), with the 12-month market performance down to -2.50% lower. […]
